Subject Areas on Research
- Acquired peanut hypersensitivity after transfusion.
- Adjuvanted Immunotherapy Approaches for Peanut Allergy.
- Clinical characteristics of peanut-allergic children: recent changes.
- Clinical efficacy and immune regulation with peanut oral immunotherapy.
- Diacylglycerol kinase ζ deficiency in a non-CD4(+) T-cell compartment leads to increased peanut hypersensitivity.
- Effect of endotoxin and alum adjuvant vaccine on peanut allergy.
- Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy.
- Nasal peanut+ CpG immunotherapy enhances peanut-specific IFN-γ in Th2 cells and IL-10 in non-Th2 cells in mice.
- Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials.
- Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
- Safety of open food challenges in the office setting.
- Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison.
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
- Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.
Keywords of People